Target (CBDY) Other Non Operating Income (2015 - 2026)
Target (CBDY) reported Other Non Operating Income of -$43.0 for Q1 2026, up 99.59% year-over-year from -$21.54 in Q1 2025, and up 99.96% quarter-over-quarter from -$98597.0 in Q4 2025.
Target (CBDY) Other Non Operating Income (2015 - 2026) Analysis & Trends
Target (CBDY) has 12 years of Other Non Operating Income data on file, last reported at -$43.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$43.0, up 99.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$162805.0 (down 224.69% YoY), and the FY2025 annual result was -$98569.0, down 26455.35% from the prior year.
- Other Non Operating Income climbed to -$43.0 in Q1 2026 per CBDY's latest filing, from -$98597.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $130870.0 in Q3 2022 and troughed at -$732739.0 in Q4 2022.
- A 5-year average of -$45850.5 and a median of -$834.0 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income soared 1599.64% in 2023, then sank 4027.78% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$732739.0 in 2022, then soared by 102.4% to $17552.0 in 2023, then slumped by 327.76% to -$39977.0 in 2024, then tumbled by 146.63% to -$98597.0 in 2025, then surged by 99.96% to -$43.0 in 2026.
- Business Quant data shows CBDY's Other Non Operating Income at -$43.0 in Q1 2026, -$98597.0 in Q4 2025, and $42454.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Target | - | - | 191,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.00 |
| Dec 31, 2025 | -98,597.00 |
| Sep 30, 2025 | 42,454.00 |
| Jun 30, 2025 | -106,619.00 |
| Mar 31, 2025 | -10,402.00 |
| Dec 31, 2024 | -39,977.00 |
| Sep 30, 2024 | 8,427.00 |
| Jun 30, 2024 | -8,189.00 |
| Mar 31, 2024 | -252.00 |
| Dec 31, 2023 | 17,552.00 |
| Sep 30, 2023 | -8,988.00 |
| Jun 30, 2023 | 12,507.00 |
| Mar 31, 2023 | -2,275.00 |
| Dec 31, 2022 | -732,739.00 |
| Sep 30, 2022 | 130,870.00 |
| Jun 30, 2022 | -834.00 |
| Mar 31, 2022 | 17,646.00 |
| Dec 31, 2021 | -87,184.00 |
| Sep 30, 2021 | 67,015.00 |
| Jun 30, 2021 | 1.45 Mn |